- Home
- RNXT vs SXTC Comparison
RNXT vs SXTC Comparison
Compare RNXT & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNXT | SXTC |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 92.9M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RNXT | SXTC |
|---|---|---|
| Price | $1.52 | $3.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.13 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 651.8K |
| Earning Date | 11-12-2026 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $244.84 | N/A |
| Revenue Next Year | $195.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.03 |
| 52 Week High | $2.59 | $6.98 |
Technical Indicators
Market Signals| Indicator | RNXT | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 59.50 |
| Support Level | $1.55 | $1.86 |
| Resistance Level | $1.80 | $5.55 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | -0.05 | 0.06 |
| Stochastic Oscillator | 22.86 | 90.72 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.